Related Experiment Video
Updated: Mar 23, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy
James G Carlucci1, Natasha Halasa1, C Buddy Creech1
1Division of Pediatric Infectious Diseases, Department of Pediatrics.
Abstract:
Therapeutics blocking the activity of tumor necrosis factor (anti-TNF) are a risk factor for invasive fungal infections; however, infectious risks to infants born to mothers receiving anti-TNF therapy are not well defined. We report a case of vertical transmission of disseminated histoplasmosis in a mother-infant pair exposed to anti-TNF therapy.
Insights
Tumor necrosis factor (TNF) inhibitors increase invasive fungal infection risk. This case shows vertical transmission of disseminated histoplasmosis from a mother to her infant exposed to anti-TNF therapy.
Area of Science:
- Immunology
- Infectious Diseases
- Maternal-Fetal Medicine
Background:
- Therapeutics targeting tumor necrosis factor (anti-TNF) are widely used for inflammatory conditions.
- Anti-TNF therapy is associated with an increased risk of invasive fungal infections in adults.
- The infectious risks to infants born to mothers receiving anti-TNF therapy remain incompletely understood.
Observation:
- A case of disseminated histoplasmosis occurred in a mother undergoing anti-TNF therapy.
- The infant born to this mother also developed disseminated histoplasmosis.
- This suggests a potential mother-to-infant transmission of the infection.
Findings:
- The study reports a case of vertical transmission of disseminated histoplasmosis.
- This transmission occurred in a mother-infant pair with exposure to anti-TNF therapy.
- This highlights a potential infectious risk associated with maternal anti-TNF use.
Implications:
- Maternal anti-TNF therapy may pose a risk for vertical transmission of certain fungal infections like histoplasmosis.
- Further research is needed to define the spectrum of infectious risks for infants exposed to anti-TNF in utero.
- Clinical vigilance for invasive fungal infections in infants born to mothers on anti-TNF therapy is warranted.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease
Tumor Immunotherapy
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Hepatitis

